List view / Grid view
7 June 2016 | By Victoria White, Digital Content Producer
A drug that affects the activity of the TST gene has been shown to reduce the symptoms of type 2 diabetes in obese mice and could lead to new treatments...
3 June 2016 | By Victoria White, Digital Content Producer
Researchers are to examine DNA samples from 20,000 people with diabetes to help identify the genetic factors in diabetic kidney disease...
10 May 2016 | By Victoria White, Digital Content Producer
Researchers have described a potential new intraocular treatment that prevents and reverses some characteristics of diabetic retinopathy in a mouse model...
28 April 2016 | By Victoria White, Digital Content Producer
A new €2.25m US-Ireland R&D partnership has been set up to develop a gene therapy approach with the aim of potentially reversing diabetes-related blindness...
22 April 2016 | By SMi Group
SMI Reports (12.04.2016): MedImmune Senior Director for R&D to present keynote address on MED10382 at the 3rd Peptides Conference in London...
12 April 2016 | By Victoria White, Digital Content Producer
The result of their research is the production of hundreds of millions of lab-produced human beta cells that are able to relieve diabetes in mice...
11 April 2016 | By Victoria White, Digital Content Producer
New research could pave the way for a new generation of anti-diabetic drugs that are activated by the presence of either blue or ultra-violet light...
30 March 2016 | By Victoria White
Scientists have discovered two enzymes - AIG1 and ADTRP - that appear to play a role in metabolism and inflammation...
24 February 2016 | By Victoria White
Researchers have discovered that the protein cathelicidin antimicrobial peptide helps the pancreas regenerate and produce insulin...
19 February 2016 | By Victoria White
The discovery could change the way researchers understand and treat autoimmune diseases such as type 1 diabetes and multiple sclerosis...
11 February 2016 | By Victoria White
New research on the blood lipid-lowering protein FGF21 shows how it redistributes fatty acids by two distinct mechanisms...
23 December 2015 | By Victoria White
ARA 290 is a first-in-class synthetic peptide designed to activate the innate repair mechanism in the setting of tissue injury...
14 December 2015 | By Victoria White
A new study outlines a way of using antibiotic resistance to find chemicals capable of stopping amyloid formation in amyloid diseases such as Parkinson’s, Alzheimer’s and type II diabetes...
11 December 2015 | By Victoria White
A new study shows how different pharmaceutical drugs hit either the "on" or "off" switch of β2AR - signalling protein linked to asthma, obesity and type 2 diabetes...
26 November 2015 | By Victoria White
Venom Knowledge Base summarises the results of 5,117 studies in the medical literature describing the use of venom toxins as painkillers and as treatments for diseases...
